Vioxx Lawsuit Funding - Lawsuit Loan Program. How Does It Work?
Risk - Free Lawsuit Settlement Funding for Vioxx Product
Liability Lawsuit Plaintiffs
Plaintiffs involved in Vioxx, Fen-Phen and Zyprexa product
liability lawsuits do not realize they can now get legal
cash advances or lawsuit funding, while they are waiting
for their lawsuit settlement money. It is called lawsuit
funding and often referred as lawsuit loan, lawsuit
financing, legal finance, legal financing, litigation
financing, pending lawsuit loan, lawsuit cash advance,
litigation funding and lawsuit advance funding.
Vioxx is a non steroidal anti-inflammatory drug (NSAID)
developed by Merck & Co. to treat osteoarthritis, acute
pain conditions, and dysmenorrhoea. Vioxx was approved as
safe and effective by the Food and Drug Administration
(FDA) on May 20, 1999. Vioxx was supposed to be the super
aspirin and block buster arthritis drug that would relieve
pain safely.
On September 30, 2004, the pharmaceutical giant Merck & Co.
had pulled Vioxx from the market following study results
confirming earlier concerns that Vioxx increases the risk
of cardiovascular problems, including heart attacks and
stroke. In the year before withdrawal, Merck had sales
revenue of US$2.5 billion from Vioxx.
U.S. Food and Drug Administration (FDA) announced in August
2004 that patients taking Vioxx have a 50% greater chance
of heart attacks and sudden cardiac death. It estimates
Vioxx may have caused up to 140,000 cases of serious heart
disease since 1999.
Vioxx was sold around the world and in all it was taken by
about 20m people. A large percentage of these people
suffered drastic side effects including blood clots, heart
attacks, and stroke. Nearly 4,200 individual and class
action Vioxx lawsuits were filed in U.S.A, because of the
different adverse effects of Vioxx.
Vioxx lawsuits fall under a category known as products
liability, claiming that the manufacturers of Vioxx (Vioxx
lawsuit defendants) or their distributors knew that the
drug could cause harm. Merck has reserved $970 million to
pay for its Vioxx-related legal expenses through 2007.
It does not seem fair for the plaintiffs, that even if they
would win their Vioxx settlement lawsuit, they may lose
because too little settlement money comes in too late. They
need money now. Most of the plaintiffs, because of their
medical conditions have missed work or lost their jobs.
They can no longer meet their mortgage/ rent, medical
bills, car payments, education expenses of their children
and other monthly bills. Many of them may be one or two
payments away from foreclosures.
But now this new risk free Vioxx lawsuit settlement funding
or litigation financing program is great help to Vioxx
product liability lawsuit plaintiffs. With a lawsuit cash
advance or pending lawsuit loan, on your Vioxx lawsuit
settlement, you reduce the financial and emotional stress
on you and your family.
But in true sense, these are not loans because the money
does not have to be paid back unless the case is won or
settled. These are non- recourse legal cash advances. It
carries no risk because Vioxx product liability lawsuit
plaintiffs pay only when they get their Vioxx settlement
money from Defendant Company.
Litigation financing or so called Lawsuit loan can help
them buy some time with a lawsuit cash advance on their
Vioxx product liability lawsuit settlement.
Vioxx Lawsuit Funding or Lawsuit Loan: How does it work?
There are many advantages of Vioxx lawsuit funding or
litigation financing Program. The process to receive
lawsuit loan or lawsuit cash advance is risk free & simple.
There are no monthly payments. The total process is
confidential, prompt and discreet.
1. Making an application for lawsuit funding or pending
lawsuit loan is free and there is no obligation. A good and
reputed litigation financing company should not charge any
upfront fee or any application fee, processing fee or any
monthly fee.
2. Plaintiff may have a bad or no credit. No employment
requirement is required to apply for a lawsuit loan or
lawsuit funding.
3. Quick and thorough underwriting process to qualify
client (some times in 6-8 hours).
4. If approved for lawsuit advance funding or lawsuit cash
advance, funds are wired into your bank account, the same
day. Of course, you can take a bank check also.
5. Plaintiff payback upon successful settlement/verdict of
case.
6. If plaintiff loses case, plaintiff owes nothing to
litigation financing or lawsuit funding company.
They can use the lawsuit loan or legal cash advance in any
way they like. They can use the money for living expenses;
pay their bills, mortgage/ rent / car payments, medical
treatment, education expenses. As a matter of fact use it
any way they like.
----------------------------------------------------
About the Author:
Paul Sherman is a Legal Funding Consultant. He offers free,
professional, and independent advice to plaintiffs (incl.
business owners) involved in lawsuits & Attorneys. To apply
for Lawsuit loan, Commercial Lawsuit funding, Law Firm
loan, Attorney funding & Structured settlement funding
please visit: http://www.easylawsuitfunding.com
Liability Lawsuit Plaintiffs
Plaintiffs involved in Vioxx, Fen-Phen and Zyprexa product
liability lawsuits do not realize they can now get legal
cash advances or lawsuit funding, while they are waiting
for their lawsuit settlement money. It is called lawsuit
funding and often referred as lawsuit loan, lawsuit
financing, legal finance, legal financing, litigation
financing, pending lawsuit loan, lawsuit cash advance,
litigation funding and lawsuit advance funding.
Vioxx is a non steroidal anti-inflammatory drug (NSAID)
developed by Merck & Co. to treat osteoarthritis, acute
pain conditions, and dysmenorrhoea. Vioxx was approved as
safe and effective by the Food and Drug Administration
(FDA) on May 20, 1999. Vioxx was supposed to be the super
aspirin and block buster arthritis drug that would relieve
pain safely.
On September 30, 2004, the pharmaceutical giant Merck & Co.
had pulled Vioxx from the market following study results
confirming earlier concerns that Vioxx increases the risk
of cardiovascular problems, including heart attacks and
stroke. In the year before withdrawal, Merck had sales
revenue of US$2.5 billion from Vioxx.
U.S. Food and Drug Administration (FDA) announced in August
2004 that patients taking Vioxx have a 50% greater chance
of heart attacks and sudden cardiac death. It estimates
Vioxx may have caused up to 140,000 cases of serious heart
disease since 1999.
Vioxx was sold around the world and in all it was taken by
about 20m people. A large percentage of these people
suffered drastic side effects including blood clots, heart
attacks, and stroke. Nearly 4,200 individual and class
action Vioxx lawsuits were filed in U.S.A, because of the
different adverse effects of Vioxx.
Vioxx lawsuits fall under a category known as products
liability, claiming that the manufacturers of Vioxx (Vioxx
lawsuit defendants) or their distributors knew that the
drug could cause harm. Merck has reserved $970 million to
pay for its Vioxx-related legal expenses through 2007.
It does not seem fair for the plaintiffs, that even if they
would win their Vioxx settlement lawsuit, they may lose
because too little settlement money comes in too late. They
need money now. Most of the plaintiffs, because of their
medical conditions have missed work or lost their jobs.
They can no longer meet their mortgage/ rent, medical
bills, car payments, education expenses of their children
and other monthly bills. Many of them may be one or two
payments away from foreclosures.
But now this new risk free Vioxx lawsuit settlement funding
or litigation financing program is great help to Vioxx
product liability lawsuit plaintiffs. With a lawsuit cash
advance or pending lawsuit loan, on your Vioxx lawsuit
settlement, you reduce the financial and emotional stress
on you and your family.
But in true sense, these are not loans because the money
does not have to be paid back unless the case is won or
settled. These are non- recourse legal cash advances. It
carries no risk because Vioxx product liability lawsuit
plaintiffs pay only when they get their Vioxx settlement
money from Defendant Company.
Litigation financing or so called Lawsuit loan can help
them buy some time with a lawsuit cash advance on their
Vioxx product liability lawsuit settlement.
Vioxx Lawsuit Funding or Lawsuit Loan: How does it work?
There are many advantages of Vioxx lawsuit funding or
litigation financing Program. The process to receive
lawsuit loan or lawsuit cash advance is risk free & simple.
There are no monthly payments. The total process is
confidential, prompt and discreet.
1. Making an application for lawsuit funding or pending
lawsuit loan is free and there is no obligation. A good and
reputed litigation financing company should not charge any
upfront fee or any application fee, processing fee or any
monthly fee.
2. Plaintiff may have a bad or no credit. No employment
requirement is required to apply for a lawsuit loan or
lawsuit funding.
3. Quick and thorough underwriting process to qualify
client (some times in 6-8 hours).
4. If approved for lawsuit advance funding or lawsuit cash
advance, funds are wired into your bank account, the same
day. Of course, you can take a bank check also.
5. Plaintiff payback upon successful settlement/verdict of
case.
6. If plaintiff loses case, plaintiff owes nothing to
litigation financing or lawsuit funding company.
They can use the lawsuit loan or legal cash advance in any
way they like. They can use the money for living expenses;
pay their bills, mortgage/ rent / car payments, medical
treatment, education expenses. As a matter of fact use it
any way they like.
----------------------------------------------------
About the Author:
Paul Sherman is a Legal Funding Consultant. He offers free,
professional, and independent advice to plaintiffs (incl.
business owners) involved in lawsuits & Attorneys. To apply
for Lawsuit loan, Commercial Lawsuit funding, Law Firm
loan, Attorney funding & Structured settlement funding
please visit: http://www.easylawsuitfunding.com
Labels: attorney, lawsuit funding, lawyer, legal

